Integrated Filing — IndAS
General information about company
| Scrip Code |
500770 |
| NSE Symbol |
TATACHEM |
| MSEI Symbol |
NOTLISTED |
| ISIN |
INE092A01019 |
| Name of company |
Tata Chemicals Limited |
| Type of company |
Main Board |
| Class of security |
Equity |
| Date of start of financial year |
01-04-2025 |
| Date of end of financial year |
31-03-2026 |
| Date of board meeting when results were approved |
02-02-2026 |
| Date on which prior intimation of the meeting for considering financial results was informed
to the exchange |
21-01-2026 |
| Description of presentation currency |
INR |
| Level of rounding used in financial results |
Lakhs |
| Reporting Type |
Quarterly |
| Reporting Quarter |
Third quarter |
| Nature of report standalone or consolidated |
Consolidated |
| Whether results are audited or unaudited for the quarter ended |
Unaudited |
| Whether results are audited or unaudited for the Year to date for current period ended/year ended |
Unaudited |
| Segment Reporting |
Multi segment |
| Description of single segment |
|
| Start date and time of board meeting |
02-02-2026 14:00:00 |
| End date and time of board meeting |
02-02-2026 16:15:00 |
| Whether cash flow statement is applicable on company |
|
| Type of cash flow statement |
|
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
Financial Results Ind-AS
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
31-12-2025 |
31-12-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
| 1 |
Income |
|
Revenue from operations |
3,55,000.00 |
11,14,600.00 |
|
Other income |
3,800.00 |
27,200.00 |
|
Total income |
3,58,800.00 |
11,41,800.00 |
| 2 |
Expenses |
| (a) |
Cost of materials consumed |
71,000.00 |
2,27,000.00 |
| (b) |
Purchases of stock-in-trade |
3,300.00 |
24,900.00 |
| (c) |
Changes in inventories of finished goods,
work-in-progress and stock-in-trade |
6,900.00 |
(600.00) |
| (d) |
Employee benefit expense |
50,500.00 |
1,53,600.00 |
| (e) |
Finance costs |
14,600.00 |
43,700.00 |
| (f) |
Depreciation, depletion and amortisation expense
|
29,300.00 |
85,800.00 |
| (f) |
Other Expenses |
| 1 |
Power and fuel |
44,400.00 |
1,33,900.00 |
| 2 |
Freight and forwarding charges |
76,700.00 |
2,18,700.00 |
| 3 |
Other expenses |
67,700.00 |
2,04,000.00 |
|
Total other expenses |
1,88,800.00 |
5,56,600.00 |
|
Total expenses |
3,64,400.00 |
10,91,000.00 |
| 3 |
Total profit before exceptional items and tax |
(5,600.00) |
50,800.00 |
| 4 |
Exceptional items |
(5,400.00) |
(11,900.00) |
| 5 |
Total profit before tax |
(11,000.00) |
38,900.00 |
| 6 |
Tax expense |
|
| 7 |
Current tax |
2,000.00 |
15,300.00 |
| 8 |
Deferred tax |
(2,400.00) |
(3,100.00) |
| 9 |
Total tax expenses |
(400.00) |
12,200.00 |
| 10 |
Net movement in regulatory deferral account balances related to profit or loss and
the related deferred tax movement |
0.00 |
0.00 |
| 11 |
Net Profit Loss for the period from
continuing operations |
(10,600.00) |
26,700.00 |
| 12 |
Profit (loss) from discontinued operations before tax |
0.00 |
0.00 |
| 13 |
Tax expense of discontinued operations |
0.00 |
0.00 |
| 14 |
Net profit (loss) from discontinued
operation after tax |
0.00 |
0.00 |
| 15 |
Share of profit (loss) of associates and joint ventures accounted for using equity
method |
3,700.00 |
13,400.00 |
| 16 |
Total profit (loss) for period |
(6,900.00) |
40,100.00 |
| 17 |
Other comprehensive income net of taxes |
95,300.00 |
1,66,700.00 |
| 18 |
Total Comprehensive Income for the period |
88,400.00 |
2,06,800.00 |
| 19 |
Total profit or loss, attributable to
|
|
|
|
Profit or loss, attributable to owners of parent |
(9,300.00) |
23,600.00 |
|
Total profit or loss, attributable to non-controlling interests |
2,400.00 |
16,500.00 |
| 20 |
Total Comprehensive income for the period attributable to |
|
|
|
Comprehensive income for the period attributable to owners of parent |
85,900.00 |
1,90,300.00 |
|
Total comprehensive income for the period attributable to owners of parent non-controlling
interests |
2,500.00 |
16,500.00 |
| 21 |
Details of equity share capital |
|
|
Paid-up equity share capital |
25,500.00 |
25,500.00 |
|
Face value of equity share capital |
10 |
10 |
| 27 |
Details of debt securities |
|
| 22 |
Reserves excluding revaluation reserve |
|
|
| 23 |
Earnings per share |
|
| i |
Earnings per equity share for continuing operations |
|
|
Basic earnings (loss) per share from continuing operations |
3.65 |
9.26 |
|
Diluted earnings (loss) per share from continuing operations |
3.65 |
9.26 |
| ii |
Earnings per equity share for discontinued operations |
|
|
Basic earnings (loss) per share from discontinued operations |
0 |
0 |
|
Diluted earnings (loss) per share from discontinued operations |
0 |
0 |
| ii |
Earnings per equity share |
|
|
Basic earnings (loss) per share from continuing
and discontinued operations |
3.65 |
9.26 |
|
Diluted earnings (loss) per share from
continuing and discontinued operations |
3.65 |
9.26 |
| 24 |
Debt equity ratio |
|
|
| 25 |
Debt service coverage ratio |
|
|
| 26 |
Interest service coverage ratio |
|
|
| 27 |
Disclosure of notes on financial results |
|
Remarks
Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results
Amount in (Lakhs)
| Particulars |
3 months/ 6 month ended (dd-mm-yyyy) |
Year to date figures for current period
ended (dd-mm-yyyy) |
| Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| Date of end of reporting
period |
31-12-2025 |
31-12-2025 |
| Whether results are audited
or unaudited |
Unaudited |
Unaudited |
| Nature of report standalone or
consolidated |
Consolidated |
Consolidated |
| 1 |
Segment Revenue (Income) |
|
(net sale/income from each segment should
be disclosed) |
| 1 |
Basic chemistry products |
2,88,700.00 |
8,58,800.00 |
| 2 |
Specialty products |
66,700.00 |
2,57,100.00 |
|
Total Segment Revenue |
3,55,400.00 |
11,15,900.00 |
|
Less: Inter segment revenue |
400.00 |
1,300.00 |
|
Revenue from operations |
3,55,000.00 |
11,14,600.00 |
| 2 |
Segment Result |
|
Profit (+) / Loss (-) before tax and
interest from each segment |
| 1 |
Basic chemistry products |
7,100.00 |
49,100.00 |
| 2 |
Specialty products |
(2,100.00) |
21,400.00 |
|
Total Profit before tax |
5,000.00 |
70,500.00 |
|
i. Finance cost |
14,600.00 |
43,700.00 |
|
ii. Other Unallocable Expenditure net off Unallocable income |
1,400.00 |
(12,100.00) |
|
Profit before tax |
(11,000.00) |
38,900.00 |
| 3 |
(Segment Asset - Segment Liabilities)
|
|
Segment Asset |
| 1 |
Basic chemistry products |
24,60,000.00 |
24,60,000.00 |
| 2 |
Specialty products |
3,29,000.00 |
3,29,000.00 |
|
Total Segment Asset |
27,89,000.00 |
27,89,000.00 |
|
Un-allocable Assets |
12,28,100.00 |
12,28,100.00 |
|
Net Segment Asset |
40,17,100.00 |
40,17,100.00 |
| 4 |
Segment Liabilities |
|
Segment Liabilities |
| 1 |
Basic chemistry products |
4,19,000.00 |
4,19,000.00 |
| 2 |
Specialty products |
1,05,600.00 |
1,05,600.00 |
|
Total Segment Liabilities |
5,24,600.00 |
5,24,600.00 |
|
Un-allocable Liabilities |
10,73,500.00 |
10,73,500.00 |
|
Net Segment Liabilities |
15,98,100.00 |
15,98,100.00 |
|
Disclosure of notes on segments |
|
Other Comprehensive Income
Amount in (Lakhs)
| Particulars |
3 months/ 6 months ended (dd-mm-yyyy) |
Year to date figures for current period ended (dd-mm-yyyy) |
| A |
Date of start of reporting period |
01-10-2025 |
01-04-2025 |
| B |
Date of end of reporting period |
31-12-2025 |
31-12-2025 |
| C |
Whether results are audited or unaudited |
Unaudited |
Unaudited |
| D |
Nature of report standalone or consolidated |
Consolidated |
Consolidated |
|
Other comprehensive income [Abstract] |
|
| 1 |
Amount of items that will not be reclassified to profit and loss |
|
| 1 |
Change in fair value of equity investments carried at fair value through OCI |
87,700.00 |
1,38,900.00 |
| 2 |
Remeasurement of defined employee benefit plans |
(500.00) |
(2,100.00) |
| 3 |
Share of other comprehensive credit /(charge) of joint ventures (net of tax) |
6,900.00 |
7,600.00 |
|
Total Amount of items that will not be reclassified to profit and loss |
94,100.00 |
1,44,400.00 |
| 2 |
Income tax relating to items that will not be reclassified to profit or loss |
8,400.00 |
15,400.00 |
| 3 |
Amount of items that will be reclassified to profit and loss |
|
| 1 |
Effective portion of cash flow hedges |
(1,200.00) |
(3,400.00) |
| 2 |
Changes in foreign currency translation reserve |
10,500.00 |
40,200.00 |
| 3 |
Share of other comprehensive (charge) / credit of joint ventures (net of tax) |
100.00 |
300.00 |
|
Total Amount of items that will be reclassified to profit and loss |
9,400.00 |
37,100.00 |
| 4 |
Income tax relating to items that will be reclassified to profit or loss |
(200.00) |
(600.00) |
| 5 |
Total Other comprehensive income |
95,300.00 |
1,66,700.00 |
Details of Impact of Audit Qualification
Amount in (Lakhs)
| Whether results are audited or unaudited |
Unaudited |
| Declaration of unmodified opinion or statement on impact of audit qualification |
Declaration of unmodified opinion |
| Auditor's opinion |
|
| Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015:
The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified
opinion for the period on Standalone results |
Yes |
| Sr No. |
Audit firm's name |
Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI |
Certificate valid upto |
| 1 |
B S R & Co. LLP |
Yes |
31-07-2028 |